[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
July 10, 2006

Etanercept or Infliximab: The Patient's Considerations

Arch Intern Med. 2006;166(13):1418. doi:10.1001/archinte.166.13.1418-a

The article by Morgan Dewitt et al1 concerning the effect of insurance coverage on the choice between etanercept and infliximab is an important addition to the effect of public policy on the delivery of medical care. I believe, however, that the authors have overemphasized the influence of the prescribing physician and have not taken into account modern practices of shared decision making with patients.

First Page Preview View Large
First page PDF preview
First page PDF preview
×